medigraphic.com
ISSN 1561-3062 (Electronic)

2014, Number 2

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2014; 40 (2)

Struma ovarii, findings of thyroid disease in the ovary

García RCA, Sandoval MDK, García AE

Language: Spanish
References: 42
Page: 206-217
PDF size: 221.37 Kb.


ABSTRACT

Introduction: the ovarian neoplasms are difficult to diagnose due to a variety of histopathological findings, controversial histologic origin and because of the thin line that divides benign tumors from malignant ones. Teratomas account to 95 % of germinal tumors and among them are the monodermal which are infrequent. Struma ovarii denominates when only thyroid tissue is present and it can lead to hyperthyroidism or become malignant.
Objective: to study clinical and histopathological characteristics from struma ovarii on patients from the Hospital Universitario de Santander from January 2005 to December 2010.
Methods: a cross sectional study was made. All patients with primary ovary tumors were taken and they were classified according to origin. Cases of Struma ovarii were selected and from them clinical manifestations, morphologic findings and thyroid hormone levels were analyzed.
Results: 410 cases (100 %) of ovary tumors were studied; 126 (30.7 %) cases were germinal, 120 (29.2 %) cases of teratomas and struma ovarii cases accounted for 4 (0.9 %).The main findings of last ones were: macroscopic solid and multinodular pattern, average tumoral size: 10 centimeters, in 3 (0.7 %) cases goiter was found and 1 (0.2 %) case had follicular carcinoma, normal thyroid hormones values, no bilaterality or primary pathology of thyroid.
Conclusions: the most frequent ovary tumors in the Hospital Universitario de Santander between January 2005 December 2010 were those with epithelial origin. The frequency of struma ovarii was 0.9 % among all ovary neoplasms. No concomitant primary pathology of thyroid was detected.


REFERENCES

  1. Kurman RJ, Shih I-M () Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27:15-60.

  2. Boyle P, Levin B (eds). World cancer report 2008. World Health Organization, Lyon; 2008.

  3. Kurian AW, Balise RR, Mc Guire V. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol. 2005;96:520-30.

  4. Zhou B, Sun Q, Cong R. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. Gynecol Oncol. 2008;108:641-51.

  5. Russo A, Calo V, Bruno L. Hereditary ovarian cancer. Crit Rev Oncol Hematol. 2009;69:28-44.

  6. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329-33.

  7. American Cancer Society. Cancer Facts and Figures 2013. Atlanta, GA: American Cancer Society; 2013.

  8. Jemal A, Siegel R, Ward E. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.

  9. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics 2010. American Cancer Society, Inc. [accessed July 21 2010]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20610543

  10. Scully RE, Sobin LH. Histological typing of ovarian tumours, 2nd ed. New York: Springer; 1999.

  11. Cho KR, Shih IM. Ovarian Cancer. Annu Rev Pathol Mech Dis. 2009;4:287-313.

  12. Witschi E. Migration of the germ cells of human embryos from the yolk sac to the primitive gonadal folds. Contrib Embryol. 1948;32:69.

  13. Rashad MH, Fathalla MF, Kerr MC. Sex chromatin andchromosome analysis in ovarian teratomas. Am J Obstet Gynecol. 1966;96:461.

  14. Linder D, Mc Caw BK, Hecht F. Parthenogenic origin ofbenign ovarian teratoma. N Engl J Med. 1975;292:63.

  15. Linder D, Power J. Further evidence for postmeiotic origin of teratomas in the human female. Ann Hum Genet. 1970;34:21.

  16. Ayhan A, Bukulmez O, Genc C, Kuramursel BS, Ayhan A. Mature cystic teratomas of the ovary. A cases series from one institution over 34 years. Eur J Obstet Gynecol. 2000;88:153.

  17. Peterson WF, Prevost EC, Edmunds FT, Huntley JM Jr, Morris FK. Benign cystic teratomas of the ovary. A clinic statistical study of 1007 cases and review of the literature. Am J Obstet Gynecol. 1955;70:368.

  18. Roth LM, Talerman A. Recent advances in the pathology and classification of ovarian germ cell tumors. Int J Gynecol Pathol. 2006;25:305.

  19. Arhelger RB, Kelly B. Strumal carcinoid. Report a case with electron microscopical observations. Arch Pathol. 1974;97:323.

  20. Devaney K, Snyder R, Norris HJ. Proliferative and histologically malignant struma ovarii: a clinic pathologic study of54 cases. Int J Gynecol Pathol. 1993;12:333.

  21. Boutross-Tadross O, Saleh R, Asa SL. Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol. 2007;18:182.

  22. Garg K, Soslow RA, Rivera M. Histologically bland "extremely well differentiated" thyroid carcinomas arising in struma ovarii recur and metastasize. Int J Gynecol Pathol. 2009;28:222.

  23. Blackwell WJ, Dockerty MB, Masson JC, Mussey RD. Dermoid cysts of the ovary: clinical and pathological significance. Am J Obstet Gynecol. 1946;51:151.

  24. Bonazzi C, Peccatori F, Colombo N, Lucchini V, Cantu MG, Mangioni C. Pure ovarian immature teratoma, a unique and curable disease: 10 years experience of 32 prospectively treated patients. Obstet Gynecol. 1994;84:598.

  25. Smith FG. Pathology and physiology of struma ovarii. Arch Surg. 1946;53:603.

  26. Szyfelbein WM, Young RH, Scully RE. Cystic struma ovarii:a frequently unrecognized tumor. A report of 20 cases. Am J Surg Pathol. 1994;18:785.

  27. De Simone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol. 2003;89(3):543-8.

  28. Roth LM, Talerman A. The enigma of struma ovarii. Pathology. 2007; 39:139-46.

  29. Muallem MZ, Harter P, Heitz F, El-Balat A. Struma ovarii recurrence with peritoneal strumosis: A case report. Journal of Solid Tumors. 2012;2(6).

  30. Talerman A, Vang R. Germ Cell Tumors of the Ovari. In: Kurman RJ (ed.). Blaustein's pathology of the female genital tract. 6th ed. New York: Springer Verlag; 2011. p. 880, 883.

  31. Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Atlas of Tumor Pathology. 3rd series, Fasicle 23. Washington, DC Armed Forces Institute of Pathology; 2012.

  32. Ho Lee Y, Gun Kim S, Hyuk Choi S, Sun Kim I, Haeng Kim S. Ovarian mature cistyc teratoma containing homunculus: a case report. J Korean Med Sci. 2003;18:905-7.

  33. Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG.. Struma ovariiascitic, hyperthyroid and asymptomatic syndromes. Ann Intern Med. 1970;72(6):883-93.

  34. Szyfelbein WM, Young RH. Scully RE. Struma ovarii simulating ovarian tumors of other types. A report of 30 cases. Am J Surg Pathol. 1995;19:21-9.

  35. Izumi T, Araki Y, Satoh H. A case report of postoperative thyroid crisis accompanied with struma ovarii. (Japanese) Masui. 1990;39:391-5.

  36. Pardo-Mindan FJ, Vázquez JJ. Malignant struma ovarii. Light and electron microscopic study. Cancer. 1983;51(2):337-43.

  37. O'Connell ME, Fisher C, Harmer CL. Malignant struma ovarii: presentation and management. Br J Radiol. 1990;63(749):360-3.

  38. Erez SE, Richart RM, Shettles LB. Hashimoto's disease in a benign cystic teratoma of the ovary. Am J Obstet Gynecol. 1965;92:273.

  39. Michels A, Haugen B. Malignant Struma Ovarii. J Clin Endocrinol Metab, April 2010;95(4):1505.

  40. Doldi N, Taccagni GL, Bassan M. Hashimoto's disease in a papillary carcinoma of the thyroid originating in a teratoma of the ovary (malignant struma ovarii). Gynecol Endocrinol. 1998;12:41-2.

  41. Tokuda Y, Hatayama T, Sakoda K. Metastasis of malignant struma ovarii to the cranial vault during pregnancy. Neurosurgery. 1993;33(3):515-8.

  42. Shaco-Levy R, Peng RY, Snyder MJ, Osmond GW. Malignant Struma Ovarii A Blinded Study of 86 Cases Assessing Which Histologic Features Correlate With Aggressive Clinical Behavior. Arch Pathol Lab Med. February 2012;136.




2020     |     www.medigraphic.com